IRITABLE BOWEL SYNDROME AS THE FIRST MANIFESTATION OF HASHIMOT'S TIROIDITIS
Abstract
Introduction: Hashimoto's thyroiditis has a complex effect on the gastrointestinal tract, which includes hormone receptor alteration, neuromuscular disorders, myopathies caused by intestinal wall infiltration. Case report: A patient born in 1976 due to moderate pain in the lower abdomen present backwards for three months, which intensifies before defecation and immediately after the same discount, occurs in the outpatient clinic. There are two to four fluid stools daily in which he did not notice the presence of mucus or blood. It negates earlier illnesses as well as diseases relevant to heredity. Physical examination provides a neat finding. Ultrasound examination of the abdomen within the age range. Thyroid ultrasound (Krupa Health Center at Uni) identifies the right flap of a 48x24x10 diametre with hypoechogenic calcified nodus 14x12 mm in diameter (meets the criteria of the American Thyroid Association for aspiration biopsy), left flap of 44x20x14 mm diameter. The following are the laboratory findings: TSH 7.66 mIU / l, FT4 6.42 pmol / l, TG 5080 ng / ml, Calcitonin 8.94 pg / ml, TG-At 24.99 Iu / ml, TPO-At 500 Iu / ml. The patient is instructed on a hygienic dietary regimen and includes spasmolytic and antidiarrheal, and referred to a nuclear medicine specialist who performs an aspiration biopsy (TBSRTC IV follicular tumor). The Oncology Consilium indicates surgery (right-sided lobectomy) with ex-tempore verification and further follow-up. Pathohistological examination of the removed right lobe excludes the presence of malignant disease (struma coloides multinodosa glandulae thyroideae). Antidiarrheal therapy is discontinued and replacement therapy is administered (Levothyroxine sodium tablets 50 mcg 1x1 tablets). Subsequent proctosigmoidoscopy shows a neat finding. One year after surgery the patient is in remission of the disease. Conclusion: Diagnostic evaluation of the thyroid gland in patients with irritable colon syndrome significantly improves quality of life, reduces occupational absenteeism and health care costs
References
2. Jandrić-Kočić M. Karakteristike anemija kod pacijenata sa Hašimotovim tiroiditisom. Sestrinska reč. 2019; 22 (79): 18-22. Available from: https://scindeks-clanci.ceon.rs/data/pdf/0354-8422/2019/0354-84221979018J.pdf
3. Daher R, Yazbeck T, Jaoude JB, Abboud B. Consequences of dysthyroidism on the digestive tract and viscera. World J Gastroenterol. 2009; 15 (23): 2834-8. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699000/.
4. Ford AC, Talley NJ, Walker MM, Jones MP. Increased prevalence of autoimmune diseases in functional gastrointestinal disorders: case–control study of 23 471 primary care patients. Aliment Pharmacol Ther. 2014; 40: 827-834. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/apt.12903.
5. Mori K, Nakagawa Y, Ozaki H. Does the gut microbiota trigger Hashimoto's thyroiditis? Discov Med 2012; 14: 321– 6. Available from: http://www.discoverymedicine.com/Kouki-Mori/2012/11/27/does-the-gut-microbiota-trigger-hashimotos-thyroiditis/.
6. Chang L, Sundaresh S, Elliott J, et al. Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndrome. Neurogastroenterol Motil. 2009; 21 (2): 149–159. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2745840/
from: https://doi.org/10.1210/jc.2018-00276.
7. Naseem MY, Jayakumari C, Nair A, Kumar AS, Beegum BM. Depression in Hypothyroidism and Risk Factors. JMSCR. 2017; 5 (3): 19478-19484. Available from: https://jmscr.igmpublication.org/v5-i3/182%20jmscr.pdf
8. Jan Kvetny, Christina Ellervik, Per Bech. Is suppressed thyroid-stimulating hormone (TSH) associated with subclinical depression in the Danish General Suburban Population Study?. Nordic Journal of Psychiatry .2015; 69:4, pages 282-286. Available from: https://www.tandfonline.com/doi/citedby/10.3109/08039488.2014.929741?scroll=top&needAccess=true.
9. Rupani K, De Sousa A, Shah N. Autoimmune thyroid disorder and recurrent depression: Clinicians must be aware of the links. Thyroid research & Practice. 2016; 13 (3): 146-147. Available from: http://www.thetrp.net/article.asp?issn=0973-0354;year=2016;volume=13;issue=3;spage=146;epage=147;aulast=Rupani.
10. Mudyanadzo TA, Hauzaree C, Yerokhina O, Architha NN, Ashqar HM. Irritable Bowel Syndrome and Depression: A Shared Pathogenesis. Cureus. 2018; 10(8):e3178. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197537/
11. Shin JE. Dose Irritable Bowel Syndrome and Dysmotility Have an Autoimmune Origin? (Neurogastroenterol Motil 2011;23:1000-1006, e459). J Neurogastroenterol Motil. 2012; 18(1): 104-5. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3271243/.
12. Ghitany Mohamed K, Nouh Hanan, Elsherbiny Tamer M, Elsayed Reha. Inflammatory bowel disease severity and activity are correlated to thyroid gland nodularity, chronic nonthyroidal illness, and thyroid autoantibodies but not thyroid dysfunction. Egyptian Journal of obesity, diabetes and endocrinology. 2017; 2 (2): 67-129. Available from: http://www.ejode.eg.net/showbackIssue.asp?issn=2356-8062;year=2016;volume=2;issue=2